Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck restructuring Programs — Total Ending Accrual Reserve ($M) ($M)
Form 10-Q / 10-K Restructuring Footnote
Latest, FY2024
564
Period ended Dec 31, 2024
Change on a year earlier
-20.8%
712 in FY2023
History
9 years
Since FY2016
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring Programs — Total Ending Accrual Reserve ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 564 | -20.8% | Form 10-Q (filed 2025-05-02) ↗ |
| FY2023 | Dec 31, 2023 | 712 | +38.8% | Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 513 | -19.5% | Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 637 | +8.7% | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 586 | -18.0% | Form 10-K (filed 2023-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 715 | +33.9% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 534 | -28.5% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 747 | +38.1% | Form 10-K (filed 2020-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 541 | – | Form 10-K (filed 2019-02-27) ↗ |
Cite this data
StockData. (2026). Merck Restructuring Programs — Total Ending Accrual Reserve ($M) ($M), annual FY2016–FY2024 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr_total_reserve
See every metric in the Merck KPI table. Data updated Oct 26, 2026.